Skip to main content

Teglutik

Generic: Riluzole

Verified·Apr 23, 2026
NDC
70726-0304
RxCUI
2058147
Route
ORAL
ICD-10 indication
K91.2

Affordability Check

How much will you actually pay for Teglutik?

In 30 seconds, see every legitimate way to afford Teglutik — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About Teglutik

What is this medication? Teglutik is a prescription medication primarily used to treat amyotrophic lateral sclerosis, which is also referred to as ALS or Lou Gehrig's disease. This condition is a progressive neurological disorder that causes the nerve cells responsible for controlling voluntary muscles to deteriorate over time. While the medication is not a cure for the disease, it is used to help extend the life of the patient or delay the need for mechanical ventilation. It belongs to a class of drugs known as benzothiazoles.

The medication contains the active ingredient riluzole and works by potentially blocking the release of glutamate, a neurotransmitter that can damage nerve cells when present in excessive amounts. Unlike standard riluzole tablets, Teglutik is an oral suspension liquid. This formulation is specifically designed to assist patients who have developed dysphagia, or difficulty swallowing, which is a common symptom as ALS progresses. It is usually administered twice a day to help manage the symptoms and progression of the neurological condition.

Copay & patient assistance

Detailed copay and financial assistance information is not publicly available for this medication at this time. Please consult your pharmacist or the manufacturer's official patient support program for more details.

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Conditions we've indexed resources for

Click a condition to see copay cards, grants, and PA rules specific to it. For the full list of FDA-approved indications, see Prescribing information above.

Prior authorization & coverage

PayerPAStep therapyCopay tier

Medicare Part D

Related drugs

How this page is sourced

  • Drug identity verified against openFDA NDC Directory.
  • Label text (when shown) originates from NLM DailyMed.
  • Copay and assistance URLs verified periodically; if you hit a broken link, tell us.

Rare-disease navigation (specialists, trials, patient communities)

Teglutik treats a rare condition. For in-depth disease pages on our sister site:

UniteRare.org is our sister site for rare-disease navigation — same editorial team, same accuracy standards.